Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glivec + Vincristine + Dexamethasone in Ph+ ALL/CML
NCT00763763Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Dec 2004
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in Acute lymphoblastic leukemia, Philadelphia chromosome positive, chronic myeloid leukemia (CML), sponsored by Assistance publique - Hôpitaux de Paris. Started Dec 2004; status: completed.
02
Drugs
03
Conditions
Acute lymphoblastic leukemia, Philadelphia chromosome positivechronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT00763763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00763763.